Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans

Obesity

Volumn 24, Issue 4, 2016, Pages 908-916

  Tonks, Katherine T ^a,b,c   Coster, Adelle Cf ^a,b   Christopher, Michael J ^d   Chaudhuri, Rima ^e   Xu, Aimin ^f   Gagnon Bartsch, Johann ^g   Chisholm, Donald J ^a,b   James, David E ^e   Meikle, Peter J ^d   Greenfield, Jerry R ^a,b,c   Samocha Bonet, Dorit ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; DIACYLGLYCEROL; GLYCEROLIPID; LYSOALKYLPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLCHOLINE; PLASMALOGEN; SPHINGOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALE; OBESITY; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; TANDEM MASS SPECTROMETRY; AGED; BLOOD; GENETICS; GLUCOSE CLAMP TECHNIQUE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ADIPOSITY; ADULT; AGED; BODY MASS INDEX; CHOLESTEROL ESTERS; DIGLYCERIDES; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; OVERWEIGHT; PLASMALOGENS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; TRIGLYCERIDES; UP-REGULATION;

EID: 84959279451     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21448     Document Type: Article

References (39)

1. Samocha-Bonet D, Dixit VD, Kahn CR, et al., Metabolically healthy and unhealthy obese-the 2013 Stock Conference report. Obes Rev 2014; 15: 697-708.
2. Coen PM, Goodpaster BH., Role of intramyocelluar lipids in human health. Trends Endocrinol Metab 2012; 23: 391-398.
3. Hannun YA, Obeid LM., Many ceramides. J Biol Chem 2011; 286: 27855-27862.
4. Raichur S, Wang ST, Chan PW, et al., CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 2014; 20: 687-695.
5. Turner N, Kowalski GM, Leslie SJ, et al., Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013; 56: 1638-1648.
6. Turpin SM, Nicholls HT, Willmes DM, et al., Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 2014; 20: 678-686.
7. Bergman BC, Hunerdosse DM, Kerege A, et al., Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia 2012; 55: 1140-1150.
8. Coen PM, Dube JJ, Amati F, et al., Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010; 59: 80-88.
9. Serlie MJ, Meijer AJ, Groener JE, et al., Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 2007; 92: 1524-1529.
10. Skovbro M, Baranowski M, Skov-Jensen C, et al., Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 2008; 51: 1253-1260.
11. Meikle PJ, Christopher MJ., Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol 2011; 22: 210-215.
12. Kulkarni H, Meikle PJ, Mamtani M, et al., Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families. J Lipid Res 2014; 55: 939-946.
13. Meikle PJ, Wong G, Barlow CK, et al., Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013; 8: e74341
14. Tonks KT, Ng Y, Miller S, et al., Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects. Diabetologia 2013; 56: 875-885.
15. Irizarry RA, Hobbs B, Collin F, et al., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
16. Gagnon-Bartsch JA, Speed TP., Using control genes to correct for unwanted variation in microarray data. Biostatistics (Oxford, England) 2012; 13: 539-552.
17. Kanehisa M, Goto S, Sato Y, et al., Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 2014; 42: D199-D205.
18. Eisenberg E, Levanon EY., Human housekeeping genes are compact. Trends Genet 2003; 19: 362-365.
19. Smyth GK., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3
20. Mootha VK, Lindgren CM, Eriksson KF, et al., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
21. Heilbronn LK, Coster AC, Campbell LV, et al., The effect of short-term overfeeding on serum lipids in healthy humans. Obesity 2013; 21: E649-E659.
22. Laviad EL, Albee L, Pankova-Kholmyansky I, et al., Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 2008; 283: 5677-5684.
23. Thrush AB, Brindley DN, Chabowski A, et al., Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in ceramide accumulation. J Clin Endocrinol Metab 2009; 94: 5053-5061.
24. Amati F, Dubé JJ, Carnero EA, et al., Skeletal-muscle triglycerides, diacylglycerols, and ceramides in insulin resistance. Diabetes 2011; 60: 2588-2597.
25. Adams JM, 2nd, Pratipanawatr T, Berria R, et al., Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53: 25-31.
26. Dube JJ, Amati F, Toledo FG, et al., Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia 2011; 54: 1147-1156.
27. Coen PM, Menshikova EV, Distefano G, Exercise and Weight Loss Improve Muscle Mitochondrial Respiration, Lipid Partitioning and Insulin Sensitivity Following Gastric Bypass Surgery. Diabetes 2015; 64: 3737-3750.
28. Holland WL, Bikman BT, Wang L-P, et al., Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011; 121: 1858-1870.
29. Holland WL, Miller RA, Wang ZV, et al., Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011; 17: 55-63.
30. Holland WL, Adams AC, Brozinick JT, et al., An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 2013; 17: 790-797.
31. Boon J, Hoy AJ, Stark R, et al., Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 2012; 62: 401-410.
32. Bergman BC, Brozinick JT, Strauss A, et al., Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am J Physiol Endocrinol Metab 2015; 309: E398-E408.
33. Wiesner P, Leidl K, Boettcher A, Schmitz G, et al., Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 2009; 50: 574-585.
34. Floegel A, Stefan N, Yu Z, et al., Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013; 62: 639-648.
35. Lehmann R, Franken H, Dammeier S, et al., Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 2013; 36: 2331-2338.
36. Oresic M, Hyotylainen T, Kotronen A, et al., Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 2013; 56: 2266-2274.
37. Puri P, Baillie RA, Wiest MM, et al., A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007; 46: 1081-1090.
38. Anastasiou CA, Kavouras SA, Lentzas Y, et al., Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism 2009; 58: 1636-1642.
39. Rhee EP, Cheng S, Larson MG, et al., Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011; 121: 1402-1411.